People taking semaglutide -- the drug sold as Ozempic and Wegovy -- had close to 40% fewer asthma attacks than comparable patients who were not, according to an analysis of routine…
A recent single-center study found that taking GLP-1 medications such as semaglutide (commonly prescribed as Ozempic or Wegovy) before bariatric surgery did not result in greater…
A new study suggests that women with type 2 diabetes or prediabetes may experience more and harsher menopause symptoms than women without those conditions.
A large observational study suggests that people with type 2 diabetes who take GLP-1 receptor agonists — drugs such as Ozempic and Mounjaro — have a lower risk of fragility fractures…
A new 60-week trial found that adults taking semaglutide (the active ingredient in Ozempic and Wegovy) maintained substantially lower calorie intake compared with people on a placebo.
Federal regulators have begun reviewing applications from Swiss drugmaker Sandoz to develop generic versions of tirzepatide medicines sold as Mounjaro and Zepbound.
A new biweekly GLP-1 injection, bofanglutide, reduced blood sugar and produced weight loss in a phase 2b randomized clinical trial, offering a potential alternative to once-weekly…
A recent large observational study suggests that GLP-1 receptor agonist (GLP-1RA) medications — widely used for type 2 diabetes and increasingly for weight loss — may be linked with a…
Starting July 1, Medicare will launch a new pilot program that lets many Part D beneficiaries buy certain GLP‑1 weight‑loss medications for $50 per month.
Summer heat poses extra risks for people taking GLP-1 medications such as Ozempic, Wegovy, or Mounjaro.
When 10-year-old Taisie Seigrist began drinking huge amounts of water and needing to urinate constantly, her mother Jennifer tested her blood sugar with a borrowed glucose meter and…
A recent analysis suggests that people who start GLP-1 medications such as Ozempic, Wegovy, or Mounjaro tend to do less physical activity after beginning treatment — even though…